KaloBios Surge Continues As Firm Names Martin Shkreli As New CEO
November 23, 2015 at 11:30 AM EST
KaloBios said the investor group led by Shkreli, has acquired 70% of its outstanding shares. The pharmaceutical company also received a commitment from Shkreli and other investors for an equity investment of at least $3 million.
